MELISSA AUBIN: Open Payments
NPI 1790155984 · WEST END, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 77 payments from 22 companies in 2025. Trend: 2023 $676 · 2024 $1,304 · 2025 $1,869
Food & beverage: $1,869
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $362 |
| Lilly USA, LLC | 11 | $267 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $167 |
| Mannkind Corporation | 6 | $134 |
| Radius Health, Inc. | 6 | $112 |
| Corcept Therapeutics | 6 | $106 |
| IBSA Pharma Inc. | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| SANOFI-AVENTIS U.S. LLC | 4 | $77 |
| BETA BIONICS, INC. | 3 | $55 |
Products named: ZEPBOUND, Wegovy, Kerendia, JARDIANCE, AFREZZA, Ozempic, Tymlos, Korlym.
Industry payments across NC — which companies pay providers there.
